一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> International Journal of Phytopharmacy >>article

International Journal of Phytopharmacy

Download PDF

Teneligliptin: DPP-4 inhibitor in the treatment of type II Diabetes Mellitus

Published:30 August 2017 DOI: 10.7439/IJPP.V7I4.4347
K. Danao, M. Shende, Rohit A. Gupta, Nitin G Dumore, U. Mahajan

Abstract

The collective review of teneligliptin as an antidibetic drug concerning about the mechanisms of action, pharmacokinetic study, pharmacodynamic study, toxicological study and dose and its contraindication. Teneligliptin is used in the treatment of type II diabetes mellitus. Teneligliptin, a third generation DPP-4 inhibitor, teneligliptin was approved by the US Food and Drug Administration on 2012 based on a large development program. Teneligliptin, a novel DPP-4 inhibitor, exhibits a unique structure characterized by five consecutive rings, which produce a potent and long-lasting effect. Teneligliptin is currently used in cases showing insufficient improvement in glycemic control even after diet control and exercise or a combination of diet control, exercise, and sulfonylurea or thiazolidine-class drugs. In adults, teneligliptin is orally administered at a dosage of 20 mg once daily, which can be increased up to 40 mg per day. Due to the metabolites of this drug are eliminated via renal and hepatic excretion so, adjustable dose is not required to renal impairment patient. In this review, all the clinical data is described. Teneligliptin shows promise in stabilizing glycemic fluctuations throughout the day and consequently suppressing the progression of diabetic complications.

Substances (4)

Related products
Procduct Name CAS Molecular Formula Supplier Price
THIAZOLIDINE 504-78-9 C3H7NS 276 suppliers $7.00-$930.18
Teneligliptin 760937-92-6 C22H30N6OS 192 suppliers $44.00-$1815.00
CAY10535 Exclusive 945716-28-9 C18H21N3O7S 13 suppliers $36.00-$1801.00
TRELAGLIPTIN(SYR-472) is a long-acting DPP-4 inhibitor. 3 suppliers Inquiry

Similar articles

IF:1.3

Teneligliptin: Heralding Change in Type 2 Diabetes

Journal of Database Management M. Maladkar,?Srividya Sankar,etc Published: 31 March 2016
IF:13

Linagliptin: in type 2 diabetes mellitus.

Drugs Lesley J Scott,etc Published: 26 March 2011
IF:13

Dapagliflozin: a review of its use in type 2 diabetes mellitus.

Drugs Greg L Plosker,etc Published: 3 December 2012
晴隆县| 巩留县| 个旧市| 罗甸县| 卢龙县| 淮安市| 建瓯市| 车致| 彭山县| 阆中市| 洛阳市| 焉耆| 察哈| 大姚县| 杨浦区| 镇远县| 西贡区| 武清区| 辽源市| 沾化县| 长沙县| 禄丰县| 波密县| 福海县| 榆中县| 肥乡县| 南昌市| 濉溪县| 扎赉特旗| 鄯善县| 富锦市| 嘉义市| 华亭县| 吉安县| 赤城县| 克拉玛依市| 庄河市| 惠来县| 九台市| 甘泉县| 正宁县|